[Skip to Navigation]
Article
April 1923

JAUNDICE IN SYPHILITIC PERSONS RECEIVING ARSENICAL MEDICATION: ITS EARLY DETECTION AND POSSIBLE PREVENTION

Author Affiliations

NEW YORK

From the Department of Dermatology, Mt. Sinai Hospital and Dispensary and the Venereal Disease Service of the Department of Health, New York City.

Arch Derm Syphilol. 1923;7(4):495-498. doi:10.1001/archderm.1923.02360100068009
Abstract

It is a well recognized fact that arsphenamin, or its analogues, is responsible for a certain number of cases of jaundice that occur in syphilitic patients. This is variously estimated as occurring in from 0.6 to 0.89 per cent, of cases. While jaundice of this origin, in the majority of instances, is not serious, in a certain percentage the process goes on to acute yellow atrophy of the liver with its invariably fatal termination. This fact renders it desirable to devise means for the detection of jaundice in its earliest stages.

It is known that the appearance of jaundice in the skin and mucous membranes and of bile in the urine depends on the concentration of bilirubin in the blood, and that jaundice never appears in the tissues or urine unless the bilirubin reaches and maintains a definite concentration in the blood. Therefore a study of the behavior of the

Add or change institution
×